A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: A double-blind placebo-controlled pilot study

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 1, 2007, Pages 191-195

  Ingber, A ^a   Cohen, Y ^b   Krimsky, M ^c   Yedgar, Saul ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Morria Biopharmaceuticals Plc   (United Kingdom)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

Contact dermatitis; Skin inflammation; Topical preparation

Indexed keywords

ALLERGEN; ARACHIDONIC ACID; LEUKOTRIENE; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PLACEBO; PROSTAGLANDIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; FOLLOW UP; HAND ECZEMA; HUMAN; PATCH TEST; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SKIN INFLAMMATION;

EID: 33947728157     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000123     Document Type: Article

References (25)

1. Yedgar S., D. Lichtenberg and E. Schnitzer. 2000. Inhibition of phospholipase A2 as a therapeutic target. Biochim. Biophys. Acta 1488:182.
2. Christie P.E. and W.R. Henderson Jr. 2002. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin. Allergy Immunol. 16:233.
3. Hashimoto T., M. Yamashita, H. Ohatan and K. Momose. 2003. Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway. J. Pharmacol. Sci. 91:8.
4. Ewer A.K. 2002. Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. Acta Paediatr. Suppl. 91:2.
5. Maury E., M.C. Prevost, M.F. Simon, D. Redoules, I. Ceruti, R. Tarroux, M. Charveron and H. Chap. 2000. Identification of two secreted phospholipases A2 in human epidermis. J. Invest. Dermatol. 114:960.
6. Sjursen W., O.L. Brekke and B. Johansen. 2000. Secretory and cytosolic phospholipase A2 regulate the long-term cytokine-induced eicosanoid production in human keratinocytes. Cytokine 12: 1189.
7. Fluhr J.W., M.J. Behne, B.E. Brown, D.G. Moskowitz, C. Selden, M. Mao-Qiang, T.M. Mauro, P.M. Elias and K.R. Feingold. 2004. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/ hydrogen antiporter-1 acidify neonatal rat stratum corneum. J. Invest. Dermatol. 122:320.
8. Burke J.R. 2001. Targeting phospholipase A2 for the treatment of inflammatory skin diseases. Curr. Opin. Investig. Drugs 2(11):1549.
9. Blackwell G.J. and R.J. Flower. 1983. Inhibition of phospholipase. Br. Med. Bull. 39:260.
10. Yedgar S., M. Krimsky and O. Schwob. 2003. Protection of cell membrane from exogenous PLA2 and related inflammatory stimuli by membrane-anchored lipid conjugates. Adv. Exp. Med. Biol. 525:97.
11. Russell A.L. 1999. Glycoaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn's disease interstitial cystitis and possibly Reiter's syndrome. Med. Hypotheses 52:297.
12. Beck G., W.C. Hermes, B.A. Yard, M. Kaszkin, D. von Zabern, J. Schulte, M. Haak, K. Prem, W. Krimsky, K. van Ackern, F.J. van der Woude and S. Yedgar. 2003. Amelioration of endotoxin-induced sepsis in rats by membrane anchored lipid conjugates. Crit. Care Med. 31:20151.
13. Beck G., B.A. Yard, J. Schulte, R. Oberacker, K. van Ackern, F.J. van Der Woude, M. Krimsky, M. Kaszkin and S. Yedgar. 2002. Inhibition of LPS-induced chemokine production in human lung endothelial cells by lipid conjugates anchored to the membrane. Br. J. Pharmacol. 135:1665.
14. Shoseyov D., H. Bibi, S. Offer, O. Schwob, M. Krimsky, M. Kleiman and S. Yedgar. 2005. Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A2. Thorax 60:747.
15. Schnitzer E., A. Dagan, M. Krimsky, D. Lichtenberg, I. Pinchuk, H. Shinar and S. Yedgar. 2000. Interaction of hyaluronic acid-linked phosphatidylethanolamine (HyPE) with LDL and its effect on the susceptibility of LDL lipids to oxidation. Chem. Phys. Lipids 104:149.
16. Branco N., I. Lee, H. Zhai and H.I. Maibach. 2005. Long-term repetitive sodium lauryl sulfate-induced irritation of the skin: an in vivo study. Contact Dermatitis 53:278.
17. Moore A.R. and D.A. Willoughby. 1995. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int. J. Tissue React. 17:153.
18. Brown M.B. and S.A. Jones. 2005. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J. Eur. Acad. Dermatol. Venereol. 19:308.
19. Hobbs R.M. and F.M. Watt. 2003. Regulation of interleukin-1 alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease. J. Biol. Chem. 278:19798.
20. Myokai F., E. Koyama, K. Nishikawa, S. Noji, Y. Murayama and S. Taniguchi. 2004. Aspects of interleukin-8 gene expression by gingival and dermal fibroblasts stimulated with interleukin-1beta or tumour necrosis factor alpha. J. Int. Acad. Periodontol. 6:21.
21. Bruch-Gerharz D., K. Fehsel, C. Suschek, G. Michel, T. Ruzicka and V. Kolb-Bachofen. 1996. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J. Exp. Med. 184:2007.
22. Ormerod A.D., C.M. Dwyer, A. Reid, P. Copeland and W.D. Thompson. 1997. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Derm. Venereol. 77:436.
23. Issekutz A.C. and T.B. Issekutz. 2002. The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J. Immunol. 168:1934.
24. Gisondi P., E. Gubinelli, B. Cocuroccia and G. Girolomoni. 2004. Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Curr. Drug Targets Inflamm. Allergy. 3:175.
25. Pinto F., T. Brenner, P. Dan, M. Krimsky and S. Yedgar. 2003. Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. Glia 44:275.